Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04094844
NA

Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation

Sponsor: University of Michigan Rogel Cancer Center

View on ClinicalTrials.gov

Summary

The purpose of this research study is to measure the effects of using a mobile phone app (Roadmap 2.0) on the health-related quality of life of caregivers and patients undergoing allogeneic/autologous hematopoietic cell transplantation (HCT).

Official title: A Randomized Trial of Roadmap 2.0

Key Details

Gender

All

Age Range

5 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

372

Start Date

2020-09-08

Completion Date

2024-08-11

Last Updated

2026-04-14

Healthy Volunteers

No

Interventions

OTHER

Wearable activity sensor

Caregivers and patients in both arms of the study will have a Fitbit wearable activity sensor to track activity and sleep.

BEHAVIORAL

Roadmap 2.0 information system

Caregivers and patients download the Roadmap 2.0 app on their mobile phones or tablets

OTHER

Survey administration

Caregivers and patients will be asked to respond to survey questions at 3 timepoints.

BEHAVIORAL

Roadmap 2.0 information system with Positive Activities

Caregivers and patients download the Roadmap 2.0 app on their mobile phones. Caregivers and patients will be instructed on how to operate Roadmap 1.0 on an iPad (inpatient only) and Roadmap 2.0 on a mobile phone (inpatient and outpatient). Caregivers download the Positive Activities app onto their mobile phone to use freely throughout inpatient and outpatient (through day 120 post-transplant). Caregiver may also use an electronic tablet provided by the study team during the patient's hospital stay.

Locations (2)

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, United States

Oregon Health & Science University

Portland, Oregon, United States